SCHEMBL4568174

SCHEMBL4568174

COC(=O)c1cccc(Cc2c(-c3ccccc3C)[nH]c3cc(OC)ccc23)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.43
MTNR1B P49286 2/20 0.43
PLA2G2A P14555 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
ALOX15 P16050 2/20 0.40
USP2 O75604 1/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
DYRK1A Q13627 2/20 0.39
PARP1 P09874 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568210 0.92 GPR17 (0.42) MTNR1AMTNR1BALDH1A1KDM4EHPGD
SCHEMBL4568184 0.90 MTNR1A (0.42) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL4568181 0.90 KDM4E (0.45) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL3706006 0.88 MTNR1A (0.48) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL4568183 0.86 MEN1 (0.38) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL4568176 0.86 MDM4 (0.41) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL4568192 0.86 KDM4E (0.42) MTNR1AMTNR1BALDH1A1HSD17B10KDM4E
SCHEMBL4568191 0.85 KDM4E (0.40) PLA2G2AALDH1A1HSD17B10KDM4EMAPT
SCHEMBL4568175 0.85 PTGS2 (0.42) MTNR1AMTNR1BPLA2G2AALDH1A1HSD17B10
SCHEMBL4568188 0.84 KDM4E (0.40) PLA2G2AALDH1A1HSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122931-A1 INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2012-05-17 US disclosed
US-20120122931-A1 INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122931-A1 INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF PTGER1, CYSLTR1, LTB4R MTNR1A 19/4885MTNR1B 14/4885PLA2G2A 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.